Role of MDSCs and cancer stem cells in non-small cell lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study looks at certain immune cells (MDSCs) and cancer stem cells in patients with non-small cell lung cancer who have surgery but no other treatments before it. The goal is to understand how these cells interact and affect the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for non-small cell lung cancer with surgery only.
- You have not had chemotherapy, radiation, or immunotherapy before your surgery.
- You have not had another cancer in the last 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at preserved tissue samples from people with lung cancer to understand why some tumors don't respond to immunotherapy drugs like PD-1/PD-L1 inhibitors. The goal is to find patterns that could help predict treatment success.
This study looks at how well immunotherapy given before surgery works for non-small cell lung cancer. It aims to help doctors understand real-world outcomes for patients who receive this treatment.
This study looks at immune cells inside lung tumors to better understand how they work. If you are having surgery for a thoracic tumor, your tissue could help researchers learn more.
This study looks at genetic information from tumor tissue of people with non-small cell lung cancer who had immunotherapy before surgery but still had some cancer cells left. The goal is to understand why the cancer did not completely respond to treatment.
This trial studies a comprehensive treatment approach for lung cancer that combines immunotherapy given before surgery with standard surgery. It aims to understand how well this approach works by analyzing your medical data and samples.
This study looks at how tumor and blood biomarker results can guide treatment for people with non-small cell lung cancer (NSCLC). Depending on the cancer stage, it may follow standard-of-care treatment plans around surgery or first-line immunotherapy.
Hear when a new Lung Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.